AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2016
Sep 9, 2016
30786_dirs_2016-09-09_cf7419b5-bef9-4ad0-888d-9ca5d430d8eb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2016-09-07
Reporting Person: GOETZ JOHN (EVP, Chief Operating Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-09-07 | Restricted Stock Units | $0 | A | 8000 | Acquired | Bio-Rad A Common Stock (8000) | Direct | |
| 2016-09-07 | Non-Qualified Stock Option (right to buy) | $159.32 | A | 8000 | Acquired | 2026-09-07 | Bio-Rad A Common Stock (8000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Bio-Rad A Common Stock | 55867.4199 | Direct |
Footnotes
F1: Includes 9.280, 53.3856 and 60.8402 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 12/31/15, 3/31/16 and 6/30/16, respectively.
F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F3: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant.
F4: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13